Image

A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy

A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The goal of this observational study is to learn about in the development process of adverse reactions of anti-PD1 immunotherapy. The main question it aims to observe:

  • The autoantibody profile of patients
  • The adverse reactions of patients
  • The changes of immune cells and cytokine in patients

Description

The goal of this observational study is to learn about the development process of adverse reactions of anti-PD1 immunotherapy. The main question it aims to observe:

  • The autoantibody profile of patients
  • The adverse reactions of patients
  • The changes of immune cells and cytokine in patients (e.g., T cell, B cell, IL-6, etc.)

Eligibility

Inclusion Criteria:

  1. Age ≥ 18 years old.
  2. Receiving anti-PD1 immunotherapy

Exclusion Criteria:

  1. Vital signs are unstable
  2. Functional impairment of immune system caused by other diseases or other reasons, such as Systemic lupus erythematosus (SLE), AIDS, etc.

Study details
    Immunotherapy
    ADR

NCT05669638

Xuanwu Hospital, Beijing

13 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.